Alirocumab
Products in Health Canada’s databases that list Alirocumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 5
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| PRALUENT (75 MG) | 02453819 | Marketed | Sanofi-Aventis Canada Inc. | |
| PRALUENT (150 MG) | 02453835 | Marketed | Sanofi-Aventis Canada Inc. | |
| PRALUENT (300 MG) | 02547732 | Marketed | Sanofi-Aventis Canada Inc. | |
| PRALUENT (75 MG) | 02453754 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | |
| PRALUENT (150 MG) | 02453762 | Cancelled Post Market | Sanofi-Aventis Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- PRALUENTJuly 20, 2026 · NOC 37936
- PRALUENTMarch 15, 2024 · NOC 33250
- PRALUENTFebruary 17, 2023 · NOC 33551
- PRALUENTJanuary 12, 2022 · NOC 33550
- PRALUENTJanuary 25, 2021 · NOC 25076
- PRALUENTJuly 31, 2019 · NOC 22486
- PRALUENTJune 4, 2019 · NOC 22232
- PRALUENTMay 17, 2018 · NOC 20872
- PRALUENTMay 15, 2018 · NOC 20861
- PRALUENTJune 6, 2017 · NOC 19381
- PRALUENT (PFP); PRALUENT (PFS)April 11, 2016 · NOC 17976